Pressreleases

PRA Named Clinical Company of the Year

PRA Health Sciences (PRA) is pleased to announce that it was once again recognized as the Best Clinical Company of the Year. PRA received the award at the PharmaTimes Clinical Researcher of the Year Americas ceremony in Cary, North Carolina. This award follows PRA’s recognition as the Best International Clinical Company of the Year which was announced earlier this year in London.

PRA Continues the Transformation of Clinical Trials with Predictivv

PRA Health Sciences, a leading global contract research organization, today announced its new Predictivv™ platform, the beginning of an entirely new approach on the role technology will play in the future of clinical development. The Predictivv™ platform will be a fully integrated solution for designing, planning and optimizing the management of global clinical studies. Designed around a unified platform that harmonizes data, processes, and people across every aspect of a clinical study, Predictivv™ will enable unprecedented adaptive intelligence and decision support for the ever-increasing complexities of the clinical development process.

Podcast – Industrial Design Considerations for Auto Injectors

The design, development and manufacturing of a successful auto injector project requires not only the seamless collaboration between the biopharmaceutical company and key partners, but also robust design and manufacturing capabilities that can ultimately reflect the desired device characteristics. With industrial design often the initial starting point of a project, possessing a strong in-house industrial team can mean more efficient communication with production teams which can lead to faster prototyping and design verification.

SanaClis Joins Top Ten CROs in Latest Nice Insight Quality Survey

SanaClis has underlined its credentials as a leading potential partner for pharma or biotech organizations that needs clinical research support in Central and Eastern Europe with an impressive showing in the latest Nice Insight ‘Top Ten’ survey.

A Dynamic Approach to Educating Industry-Ready Nanotechnology Technicians

Seattle’s Hub for Industry-Driven Nanotechnology Education (Seattle, USA), an imaginative educational body with a flexible and highly productive model for nanotechnician training, has identified dynamic light scattering particle sizing as an essential analytical technique, investing in a Zetasizer Nano from Malvern Instruments.

Low Conversion In Your Cross-Coupling Reaction?

Try Our New Phosphine "pi-allyl" Palladium Catalysts For Unprecedented Results.

The Medical Research Network Announces Strategic Partnership with World Courier to Develop Global, Patient-centric Health Solutions

New partnership focused on elevating the global reach and effectiveness of community-based clinical trials.

The Tenth Anniversary of RDD® Europe: A Great Success for the International Respiratory Drug Delivery Community

RDD® Europe 2015 hosted 450 pulmonary and nasal drug delivery experts from 31 countries at its latest conference in Antibes, France.

Viscosizer TD: A New Automated Tool for Biophysical Characterization

Malvern Instruments has launched a new system based around Taylor Dispersion Analysis (TDA) to provide researchers with a novel orthogonal technique to accelerate biopharmaceutical drug candidates through the development pipeline. The Viscosizer TD speeds up stability and formulation studies by offering unique solution-based molecular sizing capabilities, combined with relative viscosity measurement.